Learn more about the different types, as well as the benefits and side effects. Sodium-glucose transport protein 2 (SGLT2) inhibitors are a class of medications used to treat type 2 diabetes.

Ozempic is not marketed as a weight loss drug and is prescribed to those with type 2 diabetes to help manage their condition ...

SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.

Empagliflozin is an SGLT-2 (Sodium-Glucose Co-Transporter-2) inhibitor used along with diet and exercise for the treatment of type 2 diabetes or diabetes mellitus, chronic kidney disease ...

Another new class of antidiabetic drugs with potential impact on bodyweight involves the sodium–glucose cotransporter (SGLT2) inhibitors. Glucose is reabsorbed from primary urine via the high ...

Lexicon Pharmaceuticals has reported that LX4211, an inhibitor of the sodium-dependent glucose transporter 2 (SGLT2; also known as SLC5A2), significantly improved glycaemic control in a Phase II ...

Daewoong Pharmaceutical said Friday that it has submitted regulatory applications for its type 2 diabetes medication Envlo ...

FDA grants accelerated approval to Novartis' Vanrafia for IgA nephropathy, with Phase 3 data in 2026 expected to support ...

Approval was based on results from the Phase III ALIGN study, which demonstrated a significant reduction in proteinuria at 36 weeks in patients with primary immunoglobulin A nephropathy.

“CareMed is grateful for the opportunity to become a specialty pharmacy provider for Vanrafia ™ ,” said Benito Fernandez. “We are proud to add Vanrafia ™ for the treatment of primary immunoglobulin A ...